Of variants and vaccines

Nathan D Grubaugh; Sarah Cobey

doi:10.1016/j.cell.2021.11.013

Of variants and vaccines

Cell. 2021 Dec 22;184(26):6222-6223. doi: 10.1016/j.cell.2021.11.013.

Authors

Nathan D Grubaugh¹, Sarah Cobey²

Affiliations

¹ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06510, USA. Electronic address: nathan.grubaugh@yale.edu.
² Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA. Electronic address: cobey@uchicago.edu.

Abstract

In this issue of Cell, Bushman et al. show how more transmissible variants, even if they do not escape immunity, can be strongly selected during the early pandemic. This explains the dynamics of past SARS-CoV-2 variants, but as immunity increases, it is difficult to predict what will emerge next.

Publication types

Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vaccines*

Substances

COVID-19 Vaccines
Vaccines

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States